Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis
Clinical trial NCT01998984 · COMPLETED
Trial details
- NCT number
- NCT01998984
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2014-07-01
- Enrollment
- 266
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.